Received May 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 5 | 7D2Y4*VFC | IM / LA |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 2 | Y013580*VFC | IM / RA |
Parent reports onset of facial redness, rash and swelling around 1300 the day of vaccine. Progressive into the evening. Parent recorded fever of 101F at 8:00pm day of vaccines. Woke morning after, 5/1/25, with fever 103.8F and up to 105F, progressive facial rash, swelling, rash to right arm and abdomen. Parent provided with oral dose ibuprofen at home. Parent called clinic to make same day visit. Child presented to clinic 5/1/2025 at 8:20 am with red diffuse, fine papular facial rash with swelling. Fever 101.f, ibuprofen 1 hour prior at home. Tachycardic. Normotensive. Rash to right arm distal to injection site surrounding previously healing small scab/wound present prior to vaccines. Scattered streaky fine red papular rash to abdomen. No airway or acute circulatory compromise. Mild clear rhinorrhea on exam. Sent home with monitoring instructions, supportive cares with antipyrectics and cetirizine.
None
Mild Eczema
None
None
No testing completed. CBC completed same day as vaccine without any abnormal findings.